Shiraz E-Medical Journal

Published by: Kowsar
Crossmark

Predictors of Tuberculosis in HIV/AIDS Patients Referred to Behavioral Diseases Consultation Center: A Registry-Based Study in Abadan, Southwest of Iran

Salman Khazaei 1 , Leila Molaeipoor 2 , Shahab Rezaeian 3 , Erfan Ayubi 4 , 5 , Mehran Yari 6 , * , Ali Asghar Valipour 6 and Somayeh Khazaei 7
Authors Information
1 Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
2 Department of Epidemiology, Pasteur Institute of Iran, Tehran, Iran
3 Social Determinant of Health Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran
4 Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
6 Student Research Committee, Abadan School of Medical Sciences, Abadan, Iran
7 Department of Operating Room, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran
Article information
  • Shiraz E-Medical Journal: October 01, 2016, 17 (10); e41542
  • Published Online: October 26, 2016
  • Article Type: Research Article
  • Received: August 15, 2016
  • Revised: October 9, 2016
  • Accepted: October 24, 2016
  • DOI: 10.17795/semj41542

To Cite: Khazaei S, Molaeipoor L, Rezaeian S, Ayubi E, Yari M, et al. Predictors of Tuberculosis in HIV/AIDS Patients Referred to Behavioral Diseases Consultation Center: A Registry-Based Study in Abadan, Southwest of Iran, Shiraz E-Med J. 2016 ; 17(10):e41542. doi: 10.17795/semj41542.

Abstract
Copyright © 2016, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. AIDS by the numbers 2015. 2015;
  • 2. Tuberculosis and HIV, 2015. 2015;
  • 3. Fact sheet 2015. 2015;
  • 4. Nunn P, Williams B, Floyd K, Dye C, Elzinga G, Raviglione M. Tuberculosis control in the era of HIV. Nat Rev Immunol. 2005; 5(10): 819-26[DOI][PubMed]
  • 5. Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet. 2006; 367(9514): 926-37[DOI][PubMed]
  • 6. Wood R, Middelkoop K, Myer L, Grant AD, Whitelaw A, Lawn SD, et al. Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med. 2007; 175(1): 87-93[DOI][PubMed]
  • 7. Young DB, Perkins MD, Duncan K, Barry C3. Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest. 2008; 118(4): 1255-65[DOI][PubMed]
  • 8. Lawn SD, Myer L, Edwards D, Bekker LG, Wood R. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS. 2009; 23(13): 1717-25[DOI][PubMed]
  • 9. Lawn SD, Myer L, Bekker LG, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS. 2006; 20(12): 1605-12[DOI][PubMed]
  • 10. Radfar S, Taheri K, Namdari Tabar H. Practical guidelines on how to provide consulting services in behavioral disorders centers 2009;
  • 11. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2007;
  • 12. Policy Statement on Preventive Therapy Against Tuberculosis in People Living with HIV. 2005;
  • 13. Tuberculosis report global. 2012;
  • 14. Tuberculosis (TB). 2016;
  • 15. Li N, Wang Z, Sun D, Zhu Q, Sun G, Yang W, et al. HIV among plasma donors and other high-risk groups in Henan, China. J Acquir Immune Defic Syndr. 2010; 53 Suppl 1: 41-7[DOI][PubMed]
  • 16. Xu J, Tang W, Cheng S, Mahapatra T, Zhou L, Lai Y, et al. Prevalence and predictors of HIV among Chinese tuberculosis patients by provider-initiated HIV testing and counselling (PITC): a multisite study in South Central of China. PLoS One. 2014; 9(2): 89723[DOI][PubMed]
  • 17. Padmapriyadarsini C, Chandrabose J, Victor L, Hanna LE, Arunkumar N, Swaminathan S. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function. J Postgrad Med. 2006; 52(2): 92-6[PubMed]
  • 18. Ghany MG, Strader DB, Thomas DL, Seeff LB, American Association for the Study of Liver D. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009; 49(4): 1335-74[DOI][PubMed]
  • 19. Schiavini M, Angeli E, Mainini A, Zerbi P, Duca PG, Gubertini G, et al. Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985-2002. HIV Med. 2006; 7(5): 331-7[DOI][PubMed]
  • 20. Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. JAMA. 2002; 288(2): 199-206[PubMed]
  • 21. Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis. 2007; 7(6): 402-9[DOI][PubMed]
  • 22. Hermans SM, Kiragga AN, Schaefer P, Kambugu A, Hoepelman AI, Manabe YC. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa. PLoS One. 2010; 5(5): 10527[DOI][PubMed]
  • 23. Martin-Echevarria E, Serrano-Villar S, Sainz T, Moreno A, Casado JL, Dronda F, et al. Development of tuberculosis in human immunodeficiency virus infected patients receiving antiretroviral therapy. Int J Tuberc Lung Dis. 2014; 18(9): 1080-4[DOI][PubMed]
  • 24. Molaeipoor L, Poorolajal J, Mohraz M, Esmailnasab N. Predictors of tuberculosis and human immunodeficiency virus co-infection: a case-control study. Epidemiol Health. 2014; 36: 2014024[DOI][PubMed]
  • 25. Mirzaei M, Poorolajal J, Khazaei S, Saatchi M. Survival rate of AIDS disease and mortality in HIV-infected patients in Hamadan, Iran: a registry-based retrospective cohort study (1997-2011). Int J STD AIDS. 2013; 24(11): 859-66[DOI][PubMed]
  • 26. Poorolajal J, Molaeipoor L, Mohraz M, Mahjub H, Ardekani MT, Mirzapour P, et al. Predictors of progression to AIDS and mortality post-HIV infection: a long-term retrospective cohort study. AIDS Care. 2015; 27(10): 1205-12[DOI][PubMed]
  • 27. Crump JA, Wu X, Kendall MA, Ive PD, Kumwenda JJ, Grinsztejn B, et al. Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study. BMC Infect Dis. 2015; 15: 12[DOI][PubMed]
  • 28. Fenner L, Forster M, Boulle A, Phiri S, Braitstein P, Lewden C, et al. Tuberculosis in HIV programmes in lower-income countries: practices and risk factors. Int J Tuberc Lung Dis. 2011; 15(5): 620-7[DOI][PubMed]
  • 29. Nakiyingi L, Ssengooba W, Nakanjako D, Armstrong D, Holshouser M, Kirenga BJ, et al. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda. BMC Infect Dis. 2015; 15: 62[DOI][PubMed]
  • 30. Ting WY, Huang SF, Lee MC, Lin YY, Lee YC, Feng JY, et al. Gender disparities in latent tuberculosis infection in high-risk individuals: a cross-sectional study. PLoS One. 2014; 9(11): 110104[DOI][PubMed]
  • 31. Hassanzadeh J, Moradi N, Esmailnasab N, Rezaeian S, Bagheri P, Armanmehr V. The Correlation between Gender Inequalities and Their Health Related Factors in World Countries: A Global Cross-Sectional Study. Epidemiol Res Inte. 2014; 2014(2014): 1-8[DOI]
  • 32. Zumla A, Atun R, Maeurer M, Kim PS, Jean-Philippe P, Hafner R. Eliminating tuberculosis and tuberculosis-HIV co-disease in the 21st century: key perspectives, controversies, unresolved issues, and needs. J Infect Dis. 2012; 205(2): 141-6[DOI]
  • 33. Reid SE, Topp SM, Turnbull ER, Hatwiinda S, Harris JB, Maggard KR, et al. Tuberculosis and HIV control in sub-Saharan African prisons: "thinking outside the prison cell". J Infect Dis. 2012; 205 Suppl 2: 265-73[DOI][PubMed]
  • 34. Henostroza G, Topp SM, Hatwiinda S, Maggard KR, Phiri W, Harris JB, et al. The high burden of tuberculosis (TB) and human immunodeficiency virus (HIV) in a large Zambian prison: a public health alert. PLoS One. 2013; 8(8): 67338[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments